Parsippany-based Teva Pharmaceuticals USA Inc. has expanded its voluntary consumer-level recall originally initiated on April 25, 2019 in the United States of losartan potassium tablets. In a press ...
Vivimed Life Sciences has issued a voluntary recall of its losartan potassium tablets after the impurity N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) was detected. It’s used to treat high blood ...
Arbli is supplied as an peppermint-flavored oral suspension containing 10mg/mL of losartan potassium in 165mL bottles. The Food and Drug Administration (FDA) has approved Arbli ™, an oral suspension ...
Torrent Pharmaceuticals Limited has again expanded a recall of its blood pressure medication over concerns the tablets contain small amounts of a cancer-causing ingredient. In a Sept. 19 statement, ...
NEW YORK (CBSNewYork) – Another blood pressure medication has been added to the massive recall – linking the drugs to cancer-causing chemicals. The FDA announced on Thursday that Torrent ...
Another 19 lots of losartan tablets, these made by Vivimed Life Sciences and distributed by Heritage Pharmaceuticals, have been recalled for exceeding the FDA allowable amount of NMBA. “Based on the ...
Sept. 24 (UPI) --The U.S. Food and Drug administration has expanded a recall for generic blood pressure medications due to possible contamination with a cancer-causing chemical, regulators said. The ...
A recall of common blood pressure medication losartan has been expanded for a fifth time after manufacturer Torrent Pharmaceuticals found a possibly carcinogenic impurity in more batches of the drug, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback